Caricamento...
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of alpha-emitting peptide receptor radionuclide therapy (PRRT), and novel radiopeptides incorporating somatostatin receptor antagonist...
Salvato in:
| Pubblicato in: | J Clin Med |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7696369/ https://ncbi.nlm.nih.gov/pubmed/33202931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113655 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|